These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 167957)

  • 1. Properties of acidic saccharides produced by B16 melanoma cells treated with 1-methyl-3-isobutylxanthine.
    Banks J; Kreider JW; Sato C; Davidson EA
    Cancer Res; 1975 Sep; 35(9):2383-9. PubMed ID: 167957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of neoplastic cell growth by quiescent cells is mediated by serum concentration and cAMP phosphodiesterase inhibitors.
    Bertram JS; Bertram BB; Janik P
    J Cell Biochem; 1982; 18(4):515-38. PubMed ID: 6282911
    [No Abstract]   [Full Text] [Related]  

  • 3. The role of adenosine 3',5'-cyclic monophosphate in the density-dependent regulation of growth and tyrosinase activity of B-16 melanoma cells.
    Wade DR; Burkart ME
    J Cell Physiol; 1978 Mar; 94(3):265-73. PubMed ID: 202603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of a calcium-antagonist (flunarizine) on the in vitro growth of B16 mouse melanoma cells.
    Sezzi ML; Zupi G; De Luca G; Materazzi M; Bellelli L
    Anticancer Res; 1984; 4(4-5):229-34. PubMed ID: 6091526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3',5'-Cyclic nucleotide phosphodiesterase in tumor cells as potential target for tumor growth inhibition.
    Drees M; Zimmermann R; Eisenbrand G
    Cancer Res; 1993 Jul; 53(13):3058-61. PubMed ID: 8391385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic potential of isozyme-selective phosphodiesterase inhibitors in the treatment of asthma.
    Torphy TJ; Livi GP; Balcarek JM; White JR; Chilton FH; Undem BJ
    Adv Second Messenger Phosphoprotein Res; 1992; 25():289-305. PubMed ID: 1372813
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of tocopherol (vitamin E) acid succinate on morphological alterations and growth inhibition in melanoma cells in culture.
    Prasad KN; Edwards-Prasad J
    Cancer Res; 1982 Feb; 42(2):550-5. PubMed ID: 6275980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The production of acidic polysaccharides by 5-bromodeoxyuridine-treated B16 mouse melanoma cells.
    Sato C; Kreider JW; Banks J; Garlick S; Davidson EA
    Cancer Res; 1975 Sep; 35(9):2532-9. PubMed ID: 1170945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphodiesterases in vascular endothelial cells.
    Kishi Y; Ashikaga T; Numano F
    Adv Second Messenger Phosphoprotein Res; 1992; 25():201-13. PubMed ID: 1372811
    [No Abstract]   [Full Text] [Related]  

  • 10. Regulation of melanin synthesis of B16 mouse melanoma cells by 1 alpha, 25-dihydroxyvitamin D3 and retinoic acid.
    Hosoi J; Abe E; Suda T; Kuroki T
    Cancer Res; 1985 Apr; 45(4):1474-8. PubMed ID: 2983883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological manipulation of tissue cyclic AMP by inhibitors. Effects of phosphodiesterase inhibitors on the functions of platelets and vascular endothelial cells.
    Tani T; Sakurai K; Kimura Y; Ishikawa T; Hidaka H
    Adv Second Messenger Phosphoprotein Res; 1992; 25():215-27. PubMed ID: 1372812
    [No Abstract]   [Full Text] [Related]  

  • 12. Control of melanogenesis in mouse melanoma cells of varying metastatic potential.
    Niles RM; Makarski JS
    J Natl Cancer Inst; 1978 Aug; 61(2):523-6. PubMed ID: 210294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of cell division and of tyrosinase in B16 melanoma cells by imidazole: a possible role for the concept of metabolite gene regulation in mammalian cells.
    Montefiori DC; Kline EL
    J Cell Physiol; 1981 Feb; 106(2):283-91. PubMed ID: 6260821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Inhibition of cyclic nucleotide phosphodiesterase from the rod outer segments of the frog retina by 3-hydroxypyridine].
    Polianskiĭ NB; Smirnov LD; Shvedova AA; Kagan VE
    Nauchnye Doki Vyss Shkoly Biol Nauki; 1984; (1):27-31. PubMed ID: 6199045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of glycosaminoglycans of flow sorted cells: incorporation of [35S]sulfate and [3H]glucosamine into glycosaminoglycans of B16-F10 cells during the cell cycle.
    Blair OC; Burger DE; Sartorelli AC
    Cytometry; 1982 Nov; 3(3):166-71. PubMed ID: 7172938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple cyclic nucleotide phosphodiesterases in human trabecular meshwork cells.
    Zhou L; Thompson WJ; Potter DE
    Invest Ophthalmol Vis Sci; 1999 Jul; 40(8):1745-52. PubMed ID: 10393044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Outer retinal rod segment cyclic nucleotide phosphodiesterase; protein inhibitor separation, bimodal effect of GTP].
    Dumler IL; Furaev VV; Etingof RN
    Dokl Akad Nauk SSSR; 1980; 253(6):1504-8. PubMed ID: 6253254
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of isoenzyme-selective inhibitors of cyclic nucleotide phosphodiesterase on microvascular leak in guinea pig airways in vivo.
    Raeburn D; Karlsson JA
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1147-52. PubMed ID: 8263775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of the phosphodiesterase regulated by muscarinic cholinergic receptors of 1321N1 human astrocytoma cells.
    Tanner LI; Harden TK; Wells JN; Martin MW
    Mol Pharmacol; 1986 May; 29(5):455-60. PubMed ID: 2422535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alkylxanthines as adenosine receptor antagonists and membrane phosphodiesterase inhibitors in central nervous tissue: evaluation of structure-activity relationships.
    Wu PH; Phillis JW; Nye MJ
    Life Sci; 1982 Dec; 31(25):2857-67. PubMed ID: 6298531
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.